Carrie A. Van Der Weyden

305 Grattan Street
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

On the RAdR in relapsed T-cell lymphoma.

On the RAdR in relapsed T-cell lymphoma.

Journal: Blood advances
Published: May 14, 2026

Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.

Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.

Journal: Leukemia & lymphoma
Published: March 14, 2026

Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

Journal: Blood
Published: January 12, 2026

Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options.

Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options.

Journal: Leukemia & lymphoma
Published: December 25, 2025

Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression.

Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression.

Journal: Leukemia
Published: December 12, 2025

Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics.

Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics.

Journal: Journal of personalized medicine
Published: September 30, 2025

Radiotherapy dose-response of mycosis fungoides with large cell transformation.

Radiotherapy dose-response of mycosis fungoides with large cell transformation.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 29, 2025

Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome.

Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome.

Journal: Expert review of clinical immunology
Published: July 14, 2025

Langerhans cell histiocytosis presenting in the skin in adults: Clinical patterns and outcomes with skin-directed therapy.

Langerhans cell histiocytosis presenting in the skin in adults: Clinical patterns and outcomes with skin-directed therapy.

Journal: Journal of the American Academy of Dermatology
Published: April 10, 2025

Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study.

Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study.

Journal: British journal of haematology
Published: February 12, 2025

Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes.

Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes.

Journal: British journal of haematology
Published: February 10, 2025

Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation Study.

Assessment of the Tolerability and Optimal Dosing of the Combination of Brentuximab Vedotin and Lenalidomide in Patients With Relapsed or Refractory T-cell Lymphoma: Results of a Single-centre Phase 1 Dose-escalation Study.

Journal: EJHaem
Published: November 25, 2024
Showing 1-12 of 42

Last Updated: 09/26/2026